Table 2.
Baseline Characteristics of Cohort
| Overall (N = 89) | Transitioned (N = 39) | Non-transitioned (N = 44) | P-value | |
|---|---|---|---|---|
| Age, mean (SD), year | 18.3 (1.6) | 18.8 (1.6) | 18.0 (1.5) | 0.03 |
| Gender, No., % | 0.54 | |||
| Female | 59 (66%) | 14 (36%) | 13 (30%) | |
| Male | 30 (34%) | 25 (64%) | 31 (70%) | |
| Ethnicity, No., % | 0.59 | |||
| White | 72 (81%) | 31 (79%) | 37 (84%) | |
| Non-white | 17 (19%) | 8 (21%) | 7 (16%) | |
| Household income, No., % | 0.43 | |||
| < $25,000 | 11 (13%) | 4 (10%) | 7 (16%) | |
| $25,000–$45,999 | 16 (18%) | 5 (13%) | 9 (21%) | |
| $50,000–$74,999 | 13 (15%) | 5 (13%) | 8 (19%) | |
| $75,000–$99,999 | 6 (7%) | 2 (5%) | 4 (9%) | |
| $100,000–$150,000 | 8 (9%) | 4 (10%) | 4 (9%) | |
| > $150,000 | 7 (8%) | 4 (10%) | 1 (2%) | |
| Unknown | 27 (31%) | 15 (38%) | 10 (23%) | |
| Type of insurance, No., % | 0.44 | |||
| Public | 22 (26%) | 8 (22%) | 12 (29%) | |
| Private | 62 (74%) | 29 (78%) | 29 (71%) | |
| Specialty, No., % | 0.16 | |||
| Rheumatology | 50 (56%) | 19 (49%) | 28 (64%) | |
| Endocrinology | 19 (21%) | 8 (21%) | 10 (23%) | |
| Gastroenterology | 20 (23%) | 12 (31%) | 6 (14%) | |
| TRAQ domain 1 score, mean (SD) | 3.1 (1.0) | 3.2 (1.0) | 3.0 (0.8) | 0.37 |
| TRAQ domain 2 score, mean (SD) | 3.7 (0.7) | 3.9 (0.5) | 3.7 (0.9) | 0.21 |
| Duration of disease, mean (SD), year | 4.8 (3.9) | 5.2 (3.9) | 4.5 (4.0) | 0.27 |
| Have discussed transition with provider, No., % | 35 (41%) | 21 (54%) | 13 (33%) | 0.06 |
| Have seen provider independently, No., % | 0.22 | |||
| Always/Often/Sometimes | 44 (51%) | 23 (59%) | 19 (45%) | |
| Never/Rarely | 43 (49%) | 16 (41%) | 23 (55%) |
Abbreviations: TRAQ Transition Readiness Assessment Questionnaire